Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Hemophilia Treatment Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Hemophilia Treatment Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Hemophilia Treatment Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Hemophilia Treatment Market-Segmentation by Type 5.1 DDAVP 5.2 Recombinant coagulation factor 5.3 Coagulation factor derived from donated human blood 6 Global Hemophilia Treatment Market-Segmentation by Application 6.1 Hemophilia A 6.2 Hemophilia B 6.3 Hemophilia C 7 Global Hemophilia Treatment Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Baxter 8.1.1 Baxter Profile 8.1.2 Baxter Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Baxter Product/Solution Launches and Enhancements Analysis 8.1.4 Baxter Business Overview/Recent Development/Acquisitions 8.2 HUALAN BIO 8.2.1 HUALAN BIO Profile 8.2.2 HUALAN BIO Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 HUALAN BIO Product/Solution Launches and Enhancements Analysis 8.2.4 HUALAN BIO Business Overview/Recent Development/Acquisitions 8.3 Octapharma 8.3.1 Octapharma Profile 8.3.2 Octapharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Octapharma Product/Solution Launches and Enhancements Analysis 8.3.4 Octapharma Business Overview/Recent Development/Acquisitions 8.4 Bayer HealthCare 8.4.1 Bayer HealthCare Profile 8.4.2 Bayer HealthCare Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Bayer HealthCare Product/Solution Launches and Enhancements Analysis 8.4.4 Bayer HealthCare Business Overview/Recent Development/Acquisitions 8.5 Shanghai RAAS 8.5.1 Shanghai RAAS Profile 8.5.2 Shanghai RAAS Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Shanghai RAAS Product/Solution Launches and Enhancements Analysis 8.5.4 Shanghai RAAS Business Overview/Recent Development/Acquisitions 8.6 Baxter AG 8.6.1 Baxter AG Profile 8.6.2 Baxter AG Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Baxter AG Product/Solution Launches and Enhancements Analysis 8.6.4 Baxter AG Business Overview/Recent Development/Acquisitions 8.7 CSL Ltd. 8.7.1 CSL Ltd. Profile 8.7.2 CSL Ltd. Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 CSL Ltd. Product/Solution Launches and Enhancements Analysis 8.7.4 CSL Ltd. Business Overview/Recent Development/Acquisitions 8.8 Wyeth Pharmaceuticals 8.8.1 Wyeth Pharmaceuticals Profile 8.8.2 Wyeth Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Wyeth Pharmaceuticals Product/Solution Launches and Enhancements Analysis 8.8.4 Wyeth Pharmaceuticals Business Overview/Recent Development/Acquisitions 8.9 Grifols SA 8.9.1 Grifols SA Profile 8.9.2 Grifols SA Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Grifols SA Product/Solution Launches and Enhancements Analysis 8.9.4 Grifols SA Business Overview/Recent Development/Acquisitions 8.10 Novo Nordisk 8.10.1 Novo Nordisk Profile 8.10.2 Novo Nordisk Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Novo Nordisk Product/Solution Launches and Enhancements Analysis 8.10.4 Novo Nordisk Business Overview/Recent Development/Acquisitions 8.11 Shanghai Institute of Biological Products 8.11.1 Shanghai Institute of Biological Products Profile 8.11.2 Shanghai Institute of Biological Products Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 Shanghai Institute of Biological Products Product/Solution Launches and Enhancements Analysis 8.11.4 Shanghai Institute of Biological Products Business Overview/Recent Development/Acquisitions 9 Global Hemophilia Treatment Market-Segmentation by Geography 10 North America 10.1 North America Hemophilia Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Hemophilia Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Hemophilia Treatment Production Analysis from 2014-2019E 10.4 North America Hemophilia Treatment Consumption Analysis from 2014-2019E 10.5 North America Hemophilia Treatment Import and Export from 2014-2019E 10.6 North America Hemophilia Treatment Value, Production and Market Share by Type (2014-2019E) 10.7 North America Hemophilia Treatment Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Hemophilia Treatment by Country (United States, Canada) 10.8.1 North America Hemophilia Treatment Sales by Country (2014-2019E) 10.8.2 North America Hemophilia Treatment Consumption Value by Country (2014-2019E) 10.9 North America Hemophilia Treatment Market PEST Analysis 11 Europe 11.1 Europe Hemophilia Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Hemophilia Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Hemophilia Treatment Production Analysis from 2014-2019E 11.4 Europe Hemophilia Treatment Consumption Analysis from 2014-2019E 11.5 Europe Hemophilia Treatment Import and Export from 2014-2019E 11.6 Europe Hemophilia Treatment Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Hemophilia Treatment Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Hemophilia Treatment by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Hemophilia Treatment Sales by Country (2014-2019E) 11.8.2 Europe Hemophilia Treatment Consumption Value by Country (2014-2019E) 11.9 Europe Hemophilia Treatment Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Hemophilia Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Hemophilia Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Hemophilia Treatment Production Analysis from 2014-2019E 12.4 Asia-Pacific Hemophilia Treatment Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Hemophilia Treatment Import and Export from 2014-2019E 12.6 Asia-Pacific Hemophilia Treatment Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Hemophilia Treatment Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Hemophilia Treatment by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Hemophilia Treatment Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Hemophilia Treatment Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Hemophilia Treatment Market PEST Analysis 13 Latin America 13.1 Latin America Hemophilia Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Hemophilia Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Hemophilia Treatment Production Analysis from 2014-2019E 13.4 Latin America Hemophilia Treatment Consumption Analysis from 2014-2019E 13.5 Latin America Hemophilia Treatment Import and Export from 2014-2019E 13.6 Latin America Hemophilia Treatment Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Hemophilia Treatment Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Hemophilia Treatment by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Hemophilia Treatment Sales by Country (2014-2019E) 13.8.2 Latin America Hemophilia Treatment Consumption Value by Country (2014-2019E) 13.9 Latin America Hemophilia Treatment Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Hemophilia Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Hemophilia Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Hemophilia Treatment Production Analysis from 2014-2019E 14.4 Middle East & Africa Hemophilia Treatment Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Hemophilia Treatment Import and Export from 2014-2019E 14.6 Middle East & Africa Hemophilia Treatment Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Hemophilia Treatment Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Hemophilia Treatment by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Hemophilia Treatment Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Hemophilia Treatment Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Hemophilia Treatment Market PEST Analysis 15 Future Forecast of the Global Hemophilia Treatment Market from 2018-2026 15.1 Future Forecast of the Global Hemophilia Treatment Market from 2019-2026 Segment by Region 15.2 Global Hemophilia Treatment Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Hemophilia Treatment Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Hemophilia Treatment Market Value ($) and Growth Rate of Hemophilia Treatment from 2014-2026 Global Hemophilia Treatment Production and Growth Rate Segment by Product Type from 2014-2026F Global Hemophilia Treatment Consumption and Growth Rate Segment by Application from 2014-2019E Figure Hemophilia Treatment Picture Table Product Specifications of Hemophilia Treatment Table Driving Factors for this Market Table Industry News of Hemophilia Treatment Market Figure Value Chain Status of Hemophilia Treatment Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Hemophilia Treatment Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Hemophilia Treatment Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure DDAVP of Hemophilia Treatment Figure Recombinant coagulation factor of Hemophilia Treatment Figure Coagulation factor derived from donated human blood of Hemophilia Treatment Table Global Hemophilia Treatment Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Hemophilia Treatment Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hemophilia A of Hemophilia Treatment Figure Hemophilia B of Hemophilia Treatment Figure Hemophilia C of Hemophilia Treatment Table Global Hemophilia Treatment Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Hemophilia Treatment Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Hemophilia Treatment Figure Online Channel of Hemophilia Treatment Table Baxter Profile (Company Name, Plants Distribution, Sales Region) Figure Baxter Sales and Growth Rate from 2014-2019E Figure Baxter Revenue ($) and Global Market Share from 2014-2019E Table Baxter Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table HUALAN BIO Profile (Company Name, Plants Distribution, Sales Region) Figure HUALAN BIO Sales and Growth Rate from 2014-2019E Figure HUALAN BIO Revenue ($) and Global Market Share from 2014-2019E Table HUALAN BIO Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Octapharma Profile (Company Name, Plants Distribution, Sales Region) Figure Octapharma Sales and Growth Rate from 2014-2019E Figure Octapharma Revenue ($) and Global Market Share from 2014-2019E Table Octapharma Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bayer HealthCare Profile (Company Name, Plants Distribution, Sales Region) Figure Bayer HealthCare Sales and Growth Rate from 2014-2019E Figure Bayer HealthCare Revenue ($) and Global Market Share from 2014-2019E Table Bayer HealthCare Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Shanghai RAAS Profile (Company Name, Plants Distribution, Sales Region) Figure Shanghai RAAS Sales and Growth Rate from 2014-2019E Figure Shanghai RAAS Revenue ($) and Global Market Share from 2014-2019E Table Shanghai RAAS Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Baxter AG Profile (Company Name, Plants Distribution, Sales Region) Figure Baxter AG Sales and Growth Rate from 2014-2019E Figure Baxter AG Revenue ($) and Global Market Share from 2014-2019E Table Baxter AG Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table CSL Ltd. Profile (Company Name, Plants Distribution, Sales Region) Figure CSL Ltd. Sales and Growth Rate from 2014-2019E Figure CSL Ltd. Revenue ($) and Global Market Share from 2014-2019E Table CSL Ltd. Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Wyeth Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region) Figure Wyeth Pharmaceuticals Sales and Growth Rate from 2014-2019E Figure Wyeth Pharmaceuticals Revenue ($) and Global Market Share from 2014-2019E Table Wyeth Pharmaceuticals Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Grifols SA Profile (Company Name, Plants Distribution, Sales Region) Figure Grifols SA Sales and Growth Rate from 2014-2019E Figure Grifols SA Revenue ($) and Global Market Share from 2014-2019E Table Grifols SA Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novo Nordisk Profile (Company Name, Plants Distribution, Sales Region) Figure Novo Nordisk Sales and Growth Rate from 2014-2019E Figure Novo Nordisk Revenue ($) and Global Market Share from 2014-2019E Table Novo Nordisk Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Shanghai Institute of Biological Products Profile (Company Name, Plants Distribution, Sales Region) Figure Shanghai Institute of Biological Products Sales and Growth Rate from 2014-2019E Figure Shanghai Institute of Biological Products Revenue ($) and Global Market Share from 2014-2019E Table Shanghai Institute of Biological Products Hemophilia Treatment Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Hemophilia Treatment Production Value ($) by Region from 2014-2019E Table Global Hemophilia Treatment Production Value Share by Region from 2014-2019E Table Global Hemophilia Treatment Production by Region from 2014-2019E Table Global Hemophilia Treatment Consumption Value ($) by Region from 2014-2019E Table Global Hemophilia Treatment Consumption by Region from 2014-2019E Table North America Hemophilia Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Hemophilia Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Hemophilia Treatment Import and Export from 2014-2019E Table North America Hemophilia Treatment Value ($) by Type (2014-2019E) Table North America Hemophilia Treatment Production by Type (2014-2019E) Table North America Hemophilia Treatment Consumption by Application (2014-2019E) Table North America Hemophilia Treatment Consumption by Country (2014-2019E) Table North America Hemophilia Treatment Consumption Value ($) by Country (2014-2019E) Figure North America Hemophilia Treatment Market PEST Analysis Table Europe Hemophilia Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Hemophilia Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Hemophilia Treatment Import and Export from 2014-2019E Table Europe Hemophilia Treatment Value ($) by Type (2014-2019E) Table Europe Hemophilia Treatment Production by Type (2014-2019E) Table Europe Hemophilia Treatment Consumption by Application (2014-2019E) Table Europe Hemophilia Treatment Consumption by Country (2014-2019E) Table Europe Hemophilia Treatment Consumption Value ($) by Country (2014-2019E) Figure Europe Hemophilia Treatment Market PEST Analysis Table Asia-Pacific Hemophilia Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Hemophilia Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Hemophilia Treatment Import and Export from 2014-2019E Table Asia-Pacific Hemophilia Treatment Value ($) by Type (2014-2019E) Table Asia-Pacific Hemophilia Treatment Production by Type (2014-2019E) Table Asia-Pacific Hemophilia Treatment Consumption by Application (2014-2019E) Table Asia-Pacific Hemophilia Treatment Consumption by Country (2014-2019E) Table Asia-Pacific Hemophilia Treatment Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Hemophilia Treatment Market PEST Analysis Table Latin America Hemophilia Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Hemophilia Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Hemophilia Treatment Import and Export from 2014-2019E Table Latin America Hemophilia Treatment Value ($) by Type (2014-2019E) Table Latin America Hemophilia Treatment Production by Type (2014-2019E) Table Latin America Hemophilia Treatment Consumption by Application (2014-2019E) Table Latin America Hemophilia Treatment Consumption by Country (2014-2019E) Table Latin America Hemophilia Treatment Consumption Value ($) by Country (2014-2019E) Figure Latin America Hemophilia Treatment Market PEST Analysis Table Middle East & Africa Hemophilia Treatment Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Hemophilia Treatment Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Hemophilia Treatment Import and Export from 2014-2019E Table Middle East & Africa Hemophilia Treatment Value ($) by Type (2014-2019E) Table Middle East & Africa Hemophilia Treatment Production by Type (2014-2019E) Table Middle East & Africa Hemophilia Treatment Consumption by Application (2014-2019E) Table Middle East & Africa Hemophilia Treatment Consumption by Country (2014-2019E) Table Middle East & Africa Hemophilia Treatment Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Hemophilia Treatment Market PEST Analysis Table Global Hemophilia Treatment Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Hemophilia Treatment Production and Growth Rate Forecast by Region (2019-2026) Table Global Hemophilia Treatment Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Hemophilia Treatment Production and Growth Rate Forecast by Type (2019-2026) Table Global Hemophilia Treatment Consumption and Growth Rate Forecast by Application (2019-2026)